Two cholesterol drugs better than one? new study investigates
NCT ID NCT07313124
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial looked at whether taking two cholesterol-lowering drugs (rosuvastatin and ezetimibe) is more effective and safer than taking just one (rosuvastatin) for people with heart disease. 66 adults with high cholesterol were randomly assigned to one of the two treatments and followed for up to 12 weeks. The study measured changes in cholesterol levels and checked for muscle-related side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
rosuvastatin and ezetimibe
What this could lead to
If successful, this could show that a combination of two cholesterol-lowering drugs works better than one alone for heart disease patients.
What could go wrong
This is a small, completed trial with only 66 participants, so results may not apply to everyone. It also focuses on lab tests, not long-term heart outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES (CVD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beni-Suef University Hospital
Banī Suwayf, Beni Suweif Governorate, 62521, Egypt